Plenty of serologic tests for SARS-CoV-2 have been developed so far, thus documenting the importance of evaluating the relevant features of the immune response to this viral agent. The performance of these assays is currently under investigation. Amongst them, LIAISON® SARS-CoV-2 S1/S2 IgG by DiaSorin and Elecsys Anti-SARS-CoV-2 cobas® by Roche are currently used by laboratory medicine hospital departments in Italy and many other countries.
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects
Criscuolo, ElenaPrimo
;Ambrosi, Alessandro;Burioni, Roberto;Mancini, NicasioConceptualization
;Clementi, MassimoConceptualization
;Clementi, Nicola
Ultimo
Conceptualization
2021-01-01
Abstract
Plenty of serologic tests for SARS-CoV-2 have been developed so far, thus documenting the importance of evaluating the relevant features of the immune response to this viral agent. The performance of these assays is currently under investigation. Amongst them, LIAISON® SARS-CoV-2 S1/S2 IgG by DiaSorin and Elecsys Anti-SARS-CoV-2 cobas® by Roche are currently used by laboratory medicine hospital departments in Italy and many other countries.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
jmv.26605CR_CN.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Altra licenza
Dimensione
2.01 MB
Formato
Adobe PDF
|
2.01 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
